Navigation Links
International Isotopes Inc. Announces Nuclear Regulatory Commission Approval Of The Final Environmental Impact Statement For The Planned Depleted Uranium De-Conversion And Fluorine Extraction Processing Facility
Date:9/4/2012

IDAHO FALLS, Idaho, Sept. 4, 2012 /PRNewswire/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) is pleased to announce the U.S. Nuclear Regulatory Commission (NRC) has completed its review, approval, and publication of the final Environmental Impact Statement (EIS) for the Company's planned depleted uranium de-conversion and fluorine extraction processing facility.  The final EIS is published as U.S. NRC Regulation (NUREG-2113) and is available on the NRC website.  The NRC and Environmental Protection Agency (EPA) have published notices of the final EIS in the Federal Register.

The Company originally submitted its license application to the NRC in December 2009, and the NRC has been reviewing that application since that time.  The Company previously announced on May 31, 2012 the NRC had completed its approval and publication of the Safety Evaluation Report (SER) for the planned facility.  The NRC approval and the EPA's publication of the final EIS represents approval of the last documents required for the NRC construction and operating license to be issued.  The final EIS is required to be posted in the Federal Register for 30 days prior to the NRC's issuance of the license. Based upon the final EIS publication date the Company anticipates that the NRC will be issuing the license to the Company on or about the first week of October 2012.

Steve T. Laflin, President and CEO of the INIS commented, "The NRC approval of the final EIS is the last major milestone in the Company's nearly three year effort to license and construct the first ever "green" depleted uranium de-conversion and fluorine extraction processing facility in the U.S.  The conclusion of the final EIS that the facility will have a small environmental impact is indicative of the efforts the Company has made to design the plant using state of the art engineering controls and place a high priority upon environmental considerations intended to reduce the footprint and environmental influence of the facility on the south east New Mexico landscape.  I would once again like to recognize the NRC staff for their excellent coordination and communication with the Company throughout the license review process and their efforts to complete the license review process in as timely a manner as possible."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources.  The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the Company's plans to construct the first commercial depleted uranium de-conversion and fluorine extraction processing facility in the U.S. and expectations regarding the NRC issuance of the construction and operating license for the facility.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including our Annual Report on Form 10-K for the year ended December 31, 2011.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION CONTACT:

Jim Drewitz
Creative Options Communications
Investor and Public Relations
jim@jdcreativeoptions.com
www.jdcreativeoptions.com
Phone:  830-669-2466

For more information, please visit the Company web site:  www.internationalisotopes.com


'/>"/>
SOURCE International Isotopes Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
2. Bacterin International to Present at Stifel Nicolaus 2012 Healthcare Conference on September 6, 2012
3. PAREXEL International to Present at Robert Baird Healthcare Conference
4. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
5. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
6. Detailed Programmes and Agendas Available for American and International Health Care Forums
7. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
8. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
9. Bacterin International Announces Second Quarter and Six Months 2012 Financial Results
10. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
11. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... 8, 2017   Responding to Heath Ledger,s ... death of singer Chris Cornell in May, the ... offers a free online psychiatric drug side ... families about psychotropic drug risks. The father ... from an accidental overdose, has called for tighter rules on ...
(Date:6/7/2017)... Specialty Infusion Group, a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), ... location. The Iowa ... 7 cleanroom—the standard needed to compound intravenous (IV) nutrition formulations. A ... "Our new cleanroom will allow ... Iowa patients," said Phil Rielly , ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
Breaking Medicine Technology:
(Date:6/23/2017)... , ... June 23, 2017 , ... Goodcents Deli Fresh ... The restaurant is located at 4210 SW 21st St. Topeka, Kan. 66604 (near 21st ... of Graham Restaurant Group who owns three other locations in the Topeka and Bonner ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State ... 18 to 20. , The two-day conference is focused on advancing scientific knowledge ... improving patients’ lives and eliminating racial breast cancer-related disparities. The conference theme is ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... PureLife ... the endorsed amalgam separator supplier for CDA members. As part of the amalgam separator ... price of $99, saving more than $400 off the retail value. This partnership between ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland ... to 3 pm to present to graduate students exciting new and innovative hope research ... project led by The Health Improvement Service of the Western Health & Social Care ...
(Date:6/23/2017)... ... 2017 , ... All-Star Insurance, a family managed agency that offers insurance management ... announcing the launch of a new charity drive to benefit women in the area ... reveal that an estimated 252, 710 new cases of invasive or high risk breast ...
Breaking Medicine News(10 mins):